Immunology

Immunogen glycolipid transfer protein domain containing 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen glycolipid transfer protein domain containing 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

The gene GLTSCR2 (glioma tumor suppressor candidate region gene 2 protein) is mapped to human chromosome 19q. The protein localizes in the nucleolus and the nucleoplasm.

Specificity Glu-Glu-(EYMPME) epitope tag. {PNAS, 82(23):7952-54, 1985} Immunogen EE(EYMPME) peptide conjugated to KLH.

Specificity Recognizes Glucagon-Like Peptide 2 Receptor. Immunogen Synthetic peptide from the N-terminal extracellular domain of human Glucagon-Like Peptide 2 Receptor.

Specificity Specific for human glucose transporter 1 from muscle and adipose tissue. Does not cross-react with GLUT-4.

Specificity Recognizes Glut-3 in mouse and rat tissues. C terminal peptide used shows no homology to the human sequence.

GLUD1/GDH1 is a mitochondrial glutamate dehydrogenase that converts L-glutamate into alpha keto-glutarate which is an important intermediate in the TCA cycle. GLUD1/GDH1, because it metabolizes glutamate which is also an important neurotransmitter,

Immunogen glutamate dehydrogenase 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

Immunogen glutamate dehydrogenase 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

Immunogen glutamate dehydrogenase 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

Anti-GluR2 (Rabbit) antibody is suitable for use in Western Blotting. Specific conditions for reactivity should be optimized by the end user.